{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:50:40Z","timestamp":1761663040796},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2334-11-335","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T07:31:47Z","timestamp":1323156707000},"source":"Crossref","is-referenced-by-count":26,"title":["The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureusbacteremia"],"prefix":"10.1186","volume":"11","author":[{"given":"Hitoshi","family":"Honda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D","family":"Doern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Wm","family":"Michael-Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,5]]},"reference":[{"issue":"6","key":"1672_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/jama.2010.1115","volume":"304","author":"AJ Kallen","year":"2010","unstructured":"Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Patel PR, Fridkin SK: Health care-associated invasive MRSA infections, 2005-2008. JAMA. 2010, 304 (6): 641-8. 10.1001\/jama.2010.1115.","journal-title":"JAMA"},{"key":"1672_CR2","unstructured":"Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns--Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep. 2006, 55 (12): 329-32."},{"issue":"1","key":"1672_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2307\/30141354","volume":"19","author":"LO Conterno","year":"1998","unstructured":"Conterno LO, Wey SB, Castelo A: Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 1998, 19 (1): 32-7. 10.1086\/647704.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"1672_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1086\/345476","volume":"36","author":"SE Cosgrove","year":"2003","unstructured":"Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y: Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003, 36 (1): 53-9. 10.1086\/345476.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1672_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/clinids\/21.6.1417","volume":"21","author":"J Romero-Vivas","year":"1995","unstructured":"Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ: Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1995, 21 (6): 1417-23. 10.1093\/clinids\/21.6.1417.","journal-title":"Clin Infect Dis"},{"issue":"17","key":"1672_CR6","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1001\/archinte.167.17.1861","volume":"167","author":"C Hawkins","year":"2007","unstructured":"Hawkins C, Huang J, Jin N, Noskin GA, Zembower TR, Bolon M: Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes. Arch Intern Med. 2007, 167 (17): 1861-7. 10.1001\/archinte.167.17.1861.","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"1672_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/491708","volume":"42","author":"RC Moellering Jr","year":"2006","unstructured":"Moellering RC: Vancomycin: a 50-year reassessment. Clin Infect Dis. 2006, 42 (Suppl 1): S3-4.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1672_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1086\/381202","volume":"38","author":"BP Howden","year":"2004","unstructured":"Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K, Bak N, Hurley J, Johnson PD, Morris AJ, Mayall BC, Grayson ML: Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis. 2004, 38 (4): 521-8. 10.1086\/381202.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1672_CR9","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1128\/AAC.00113-08","volume":"52","author":"TP Lodise","year":"2008","unstructured":"Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, Stellrecht K: Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother. 2008, 52 (9): 3315-20. 10.1128\/AAC.00113-08.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1672_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/524667","volume":"46","author":"A Soriano","year":"2008","unstructured":"Soriano A, Marco F, Martinez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J: Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008, 46 (2): 193-200. 10.1086\/524667.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1672_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1086\/513203","volume":"44","author":"FC Tenover","year":"2007","unstructured":"Tenover FC, Moellering RC: The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis. 2007, 44 (9): 1208-15. 10.1086\/513203.","journal-title":"Clin Infect Dis"},{"key":"1672_CR12","doi-asserted-by":"crossref","unstructured":"Lalueza A, Chaves F, San Juan R, Daskalaki M, Otero JR, Aguado JM: Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?. J Infect Dis. 2010, 311-2. author reply 2-3, 2","DOI":"10.1086\/649572"},{"issue":"6","key":"1672_CR13","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1128\/JCM.02135-08","volume":"47","author":"AC Musta","year":"2009","unstructured":"Musta AC, Riederer K, Shemes S, Chase P, Jose J, Johnson LB, Khatib R: Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years. J Clin Microbiol. 2009, 47 (6): 1640-4. 10.1128\/JCM.02135-08.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1672_CR14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1086\/597359","volume":"48","author":"J Price","year":"2009","unstructured":"Price J, Atkinson S, Llewelyn M, Paul J: Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin. Clin Infect Dis. 2009, 48 (7): 997-8. 10.1086\/597359.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1672_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jac\/dkl393","volume":"58","author":"GL French","year":"2006","unstructured":"French GL: Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. J Antimicrob Chemother. 2006, 58 (6): 1107-17. 10.1093\/jac\/dkl393.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"1672_CR16","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1086\/491710","volume":"42","author":"RN Jones","year":"2006","unstructured":"Jones RN: Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis. 2006, 42 (Suppl 1): S13-24.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1672_CR17","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1128\/AAC.01491-05","volume":"50","author":"HS Sader","year":"2006","unstructured":"Sader HS, Fritsche TR, Jones RN: Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob Agents Chemother. 2006, 50 (7): 2330-6. 10.1128\/AAC.01491-05.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1672_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jac\/42.2.189","volume":"42","author":"J May","year":"1998","unstructured":"May J, Shannon K, King A, French G: Glycopeptide tolerance in Staphylococcus aureus. J Antimicrob Chemother. 1998, 42 (2): 189-97. 10.1093\/jac\/42.2.189.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1672_CR19","first-page":"6","volume":"9","author":"J Quinn","year":"2008","unstructured":"Quinn J, Kramer N, McDermott D: Validation of the Social Security Death Index (SSDI): An Important Readily-Available Outcomes Database for Researchers. West J Emerg Med. 2008, 9 (1): 6-8.","journal-title":"West J Emerg Med"},{"issue":"7","key":"1672_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1086\/529190","volume":"46","author":"TC Jenkins","year":"2008","unstructured":"Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ: Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008, 46 (7): 1000-8. 10.1086\/529190.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1672_CR21","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3201\/eid1212.060505","volume":"12","author":"RM Klevens","year":"2006","unstructured":"Klevens RM, Morrison MA, Fridkin SK, Reingold A, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Fosheim G, McDougal LK, Tenover FC: Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis. 2006, 12 (12): 1991-3. 10.3201\/eid1212.060505.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"1672_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1378\/chest.130.4.947","volume":"130","author":"MN Jeffres","year":"2006","unstructured":"Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie DJ, Micek ST, Kollef MH: Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest. 2006, 130 (4): 947-55. 10.1378\/chest.130.4.947.","journal-title":"Chest"},{"issue":"12","key":"1672_CR23","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1086\/421092","volume":"38","author":"PA Moise-Broder","year":"2004","unstructured":"Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering RC: Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis. 2004, 38 (12): 1700-5. 10.1086\/421092.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1672_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Craig W, Billeter M, Dalovisio JR, Levine DP: Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009, 66 (1): 82-98. 10.2146\/ajhp080434.","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"1672_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/600884","volume":"49","author":"TP Lodise","year":"2009","unstructured":"Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL: Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis. 2009, 49 (4): 507-14. 10.1086\/600884.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1672_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1128\/AAC.30.4.521","volume":"30","author":"E Tuomanen","year":"1986","unstructured":"Tuomanen E, Durack DT, Tomasz A: Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother. 1986, 30 (4): 521-7.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1672_CR27","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1086\/377540","volume":"37","author":"SH Kim","year":"2003","unstructured":"Kim SH, Park WB, Lee KD, Kang CI, Kim HB, Oh MD, Kim EC, Choe KW: Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis. 2003, 37 (6): 794-9. 10.1086\/377540.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1672_CR28","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/archinte.159.11.1244","volume":"159","author":"RS McClelland","year":"1999","unstructured":"McClelland RS, Fowler VG, Sanders LL, Gottlieb G, Kong LK, Sexton DJ, Schmader K, Lanclos KD, Corey R: Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med. 1999, 159 (11): 1244-7. 10.1001\/archinte.159.11.1244.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1672_CR29","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1086\/317421","volume":"31","author":"JM Mylotte","year":"2000","unstructured":"Mylotte JM, Tayara A: Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis. 2000, 31 (5): 1170-4. 10.1086\/317421.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1672_CR30","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0735-1097(97)00250-7","volume":"30","author":"VG Fowler Jr","year":"1997","unstructured":"Fowler VG, Li J, Corey GR, Boley J, Marr KA, Gopal AK, Kong LK, Gottlieb G, Donovan CL, Sexton DJ, Ryan T: Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol. 1997, 30 (4): 1072-8. 10.1016\/S0735-1097(97)00250-7.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1672_CR31","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1086\/423145","volume":"190","author":"VG Fowler Jr","year":"2004","unstructured":"Fowler VG, Sakoulas G, McIntyre LM, Meka VG, Arbeit RD, Cabell CH, Stryjewski ME, Eliopoulos GM, Reller LB, Corey GR, Jones T, Lucindo N, Yeaman MR, Bayer AS: Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J Infect Dis. 2004, 190 (6): 1140-9. 10.1086\/423145.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-335\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T18:24:22Z","timestamp":1581963862000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1672"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-335","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"article-number":"335"}}